Analyzing the Coronary Heart Disease Mortality Decline in a Mediterranean Population: Spain 1988-2005

被引:0
|
作者
Flores-Mateo, Gemma [2 ]
Grau, Maria [3 ]
O'Flaherty, Martin [1 ]
Ramos, Rafel [4 ]
Elosua, Roberto [3 ,5 ]
Violan-Fors, Concepcion
Quesada, Miquel [4 ]
Marti, Ruth [4 ]
Sala, Joan [6 ]
Marrugat, Jaume [3 ]
Capewell, Simon [1 ]
机构
[1] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England
[2] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain
[3] Inst Recerca Hosp del Mar IMIM, Grp Epidemiol & Genet Cardiovasc, Programa Invest Proc Inflamatorios & Cardiovasc, Barcelona, Spain
[4] Inst Catala Salut, Unitat Suport Recerca Girona, Inst Invest Atencio Primaria Jordi Gol, Barcelona, Spain
[5] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, Madrid, Spain
[6] Hosp Univ Dr Josep Trueta, Dept Cardiol, Girona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2011年 / 64卷 / 11期
基金
英国医学研究理事会;
关键词
Coronary disease; Mortality; Drugs; Risk factors; Population; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; TRENDS; ADULTS; CARE; SENSITIVITY; PREVALENCE; COUNTRIES; DECREASE; THERAPY;
D O I
10.1016/j.rec.2011.05.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: To examine the extent to which the decrease in mortality rates in Spain between 1988 and 2005 could be explained by changes in cardiovascular risk factors and by the use of medical and surgical treatments. Methods: We used the previously validated IMPACT model to examine the contributions of exposure factors (risk factors and treatments) to the main outcome, changes in the mortality rates of death from coronary heart disease, among adults 35 to 74 years of age. Main data sources included official mortality statistics, results of longitudinal studies, national surveys, randomized controlled trials, and meta-analyses. The difference between observed and expected coronary heart disease deaths in 2005 was then partitioned between treatments and risk factors. Results: From 1988 to 2005, the age-adjusted coronary heart disease mortality rates fell by almost 40%, resulting in 8530 fewer coronary heart disease deaths in 2005. Approximately 47% of the fall in deaths was attributed to treatments. The major treatment contributions came from initial therapy for acute coronary syndromes (11%), secondary prevention (10%), and heart failure (9%). About 50% of the fall in mortality was attributed to changes in risk factors. The largest mortality benefit came from changes in total cholesterol (about 31% of the mortality fall) and in systolic blood pressure (about 15%). However, some substantial gender differences were observed in risk factor trends with an increase in diabetes and obesity in men and an increase in smoking in young women. These generated additional deaths. Conclusions: Approximately half of the coronary heart disease mortality fall in Spain was attributable to reductions in major risk factors, and half to evidence-based therapies. These results increase understanding of past trends and will help to inform planning for future prevention and treatment strategies in low-risk populations. (C) 2011 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S. L. All rights reserved.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
  • [31] Regional variation in coronary heart disease mortality trends in Portugal, 1981-2012
    Araujo, Carla
    Pereira, Marta
    Viana, Marta
    Rocha, Olga Laszczynska
    Bennett, Kathleen
    Lunet, Nuno
    Azevedo, Ana
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 224 : 279 - 285
  • [32] Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006
    Kabir, Zubair
    Perry, Ivan J.
    Critchley, Julia
    O'Flaherty, Martin
    Capewell, Simon
    Bennett, Kathleen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2462 - 2467
  • [33] Coronary heart disease and mortality following a breast cancer diagnosis
    Guo, Aixia
    Zhang, Kathleen W.
    Reynolds, Kristi
    Foraker, Randi E.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
  • [34] Relationship Between Metabolic Syndrome and Ischemic Heart Disease Mortality in Spain
    Leon Latre, Montserrat
    Andres, Eva M.
    Cordero, Alberto
    Pascual, Isaac
    Vispe, Cristina
    Laclaustra, Martin
    Luengo, Emilio
    Antonio Casasnovas, Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (12): : 1469 - 1472
  • [35] Leukocyte Telomere Length and Risks of Incident Coronary Heart Disease and Mortality in a Racially Diverse Population of Postmenopausal Women
    Carty, Cara L.
    Kooperberg, Charles
    Liu, Jingmin
    Herndon, Megan
    Assimes, Themistocles
    Hou, Lifang
    Kroenke, Candyce H.
    LaCroix, Andrea Z.
    Kimura, Masayuki
    Aviv, Abraham
    Reiner, Alexander P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (10) : 2225 - 2231
  • [36] The treatment of coronary heart disease: An update - Part 2: Mortality trends and main causes of death in the Greek population
    Chimonas, ET
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (01) : 27 - 33
  • [37] CHOLESTEROL AND CORONARY HEART-DISEASE MORTALITY
    SLEIGHT, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (05): : 576 - 579
  • [38] Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
    Preis, Sarah Rosner
    Hwang, Shih-Jen
    Coady, Sean
    Pencina, Michael J.
    D'Agostino, Ralph B., Sr.
    Savage, Peter J.
    Levy, Daniel
    Fox, Caroline S.
    CIRCULATION, 2009, 119 (13) : 1728 - U65
  • [39] Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study
    Scholes, Shaun
    Bajekal, Madhavi
    Norman, Paul
    O'Flaherty, Martin
    Hawkins, Nathaniel
    Kivimaeki, Mika
    Capewell, Simon
    Raine, Rosalind
    PLOS ONE, 2013, 8 (07):
  • [40] Development of mortality and morbidity of vascular diseases. Variations between coronary heart disease and stroke
    Heuschmann, P. U.
    Neuhauser, H. K.
    Endres, M.
    NERVENARZT, 2011, 82 (02): : 145 - +